Aileron Therapeutics Cash from Investing (TTM) Trends

Aileron Therapeutics Inc (ALRN)

3.76 0.00 (0.00%) USD | NASDAQ | May 03, 16:00

3.76 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	16.20M
September 30, 2023	21.06M
June 30, 2023	24.70M
March 31, 2023	22.06M
December 31, 2022	26.46M
September 30, 2022	23.95M
June 30, 2022	23.85M
March 31, 2022	13.19M
December 31, 2021	-35.92M
September 30, 2021	-38.52M
June 30, 2021	-47.14M
March 31, 2021	-42.11M
December 31, 2020	6.411M
September 30, 2020	11.53M
June 30, 2020	19.80M

Date	Value
March 31, 2020	0.271M
December 31, 2019	-2.814M
September 30, 2019	0.727M
June 30, 2019	-1.606M
March 31, 2019	30.26M
December 31, 2018	24.69M
September 30, 2018	20.90M
June 30, 2018	-21.94M
March 31, 2018	-29.21M
December 31, 2017	-38.91M
September 30, 2017	-41.94M
June 30, 2017	4.027M
March 31, 2017	3.064M
December 31, 2016	-0.025M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-47.14M

Minimum

Jun 2021

26.46M

Maximum

Dec 2022

2.215M

Average

11.53M

Median

Sep 2020

Cash from Investing (TTM) Benchmarks